141 related articles for article (PubMed ID: 30630020)
1. 5-Fluorouracil impairs attention and dopamine release in rats.
Jarmolowicz DP; Gehringer R; Lemley SM; Sofis MJ; Kaplan S; Johnson MA
Behav Brain Res; 2019 Apr; 362():319-322. PubMed ID: 30630020
[TBL] [Abstract][Full Text] [Related]
2. Impaired Brain Dopamine and Serotonin Release and Uptake in Wistar Rats Following Treatment with Carboplatin.
Kaplan SV; Limbocker RA; Gehringer RC; Divis JL; Osterhaus GL; Newby MD; Sofis MJ; Jarmolowicz DP; Newman BD; Mathews TA; Johnson MA
ACS Chem Neurosci; 2016 Jun; 7(6):689-99. PubMed ID: 27145395
[TBL] [Abstract][Full Text] [Related]
3. Effects of acute administration of melatonin on attentional, executive, and working memory processes in rats.
Liet C; Amenouche F; Freret T; Boulouard M; Mauvieux B; Lelong-Boulouard V; Bocca ML
Fundam Clin Pharmacol; 2015 Oct; 29(5):472-7. PubMed ID: 26194194
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced long-term alteration of executive functions and hippocampal cell proliferation: role of glucose as adjuvant.
Dubois M; Lapinte N; Villier V; Lecointre C; Roy V; Tonon MC; Gandolfo P; Joly F; Hilber P; Castel H
Neuropharmacology; 2014 Apr; 79():234-48. PubMed ID: 24291465
[TBL] [Abstract][Full Text] [Related]
5. Executive function.
Talpos J; Shoaib M
Handb Exp Pharmacol; 2015; 228():191-213. PubMed ID: 25977083
[TBL] [Abstract][Full Text] [Related]
6. KU32 prevents 5-fluorouracil induced cognitive impairment.
Sofis MJ; Jarmolowicz DP; Kaplan SV; Gehringer RC; Lemley SM; Garg G; Blagg BS; Johnson MA
Behav Brain Res; 2017 Jun; 329():186-190. PubMed ID: 28359881
[TBL] [Abstract][Full Text] [Related]
7. A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medial prefrontal cortex.
Fletcher PJ; Tenn CC; Sinyard J; Rizos Z; Kapur S
Neuropsychopharmacology; 2007 May; 32(5):1122-32. PubMed ID: 17047670
[TBL] [Abstract][Full Text] [Related]
8. Nicotine improves performance in an attentional set shifting task in rats.
Allison C; Shoaib M
Neuropharmacology; 2013 Jan; 64():314-20. PubMed ID: 22776507
[TBL] [Abstract][Full Text] [Related]
9. Part II. Cognitive domains for pharmacological intervention: implications for neuropsychiatric and neurological illnesses.
Handb Exp Pharmacol; 2015; 228():157-9. PubMed ID: 26317140
[No Abstract] [Full Text] [Related]
10. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
Hanna-Pladdy B; Pahwa R; Lyons KE
J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
[TBL] [Abstract][Full Text] [Related]
11. MAM (E17) rodent developmental model of neuropsychiatric disease: disruptions in learning and dysregulation of nucleus accumbens dopamine release, but spared executive function.
Howe WM; Tierney PL; Young DA; Oomen C; Kozak R
Psychopharmacology (Berl); 2015 Nov; 232(21-22):4113-27. PubMed ID: 25963563
[TBL] [Abstract][Full Text] [Related]
12. D4 dopamine receptor-specific antagonist improves reversal learning impairment in amphetamine-treated male rats.
Connolly NP; Gomez-Serrano M
Exp Clin Psychopharmacol; 2014 Dec; 22(6):557-64. PubMed ID: 25330246
[TBL] [Abstract][Full Text] [Related]
13. Impairment of intradimensional shift in an attentional set-shifting task in rats with chronic bilateral common carotid artery occlusion.
Kim DH; Choi BR; Jeon WK; Han JS
Behav Brain Res; 2016 Jan; 296():169-176. PubMed ID: 26365458
[TBL] [Abstract][Full Text] [Related]
14. Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats.
Nikiforuk A; Gołembiowska K; Popik P
Eur Neuropsychopharmacol; 2010 Jan; 20(1):37-48. PubMed ID: 19729284
[TBL] [Abstract][Full Text] [Related]
15. Attentional set-shifting in rodents: a review of behavioural methods and pharmacological results.
Tait DS; Chase EA; Brown VJ
Curr Pharm Des; 2014; 20(31):5046-59. PubMed ID: 24345263
[TBL] [Abstract][Full Text] [Related]
16. Electrochemical Measurement of Dopamine Release and Uptake in Zebrafish Following Treatment with Carboplatin.
Field TM; Shin M; Stucky CS; Loomis J; Johnson MA
Chemphyschem; 2018 May; 19(10):1192-1196. PubMed ID: 29573086
[TBL] [Abstract][Full Text] [Related]
17. The attentional set-shifting test paradigm in rats for the screening of novel pro-cognitive compounds with relevance for cognitive deficits in schizophrenia.
Denis Goetghebeur PJ; Dias R
Curr Pharm Des; 2014; 20(31):5060-8. PubMed ID: 24345267
[TBL] [Abstract][Full Text] [Related]
18. Chronic treatment with desipramine improves cognitive performance of rats in an attentional set-shifting test.
Lapiz MD; Bondi CO; Morilak DA
Neuropsychopharmacology; 2007 May; 32(5):1000-10. PubMed ID: 17077810
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease.
Lewis SJ; Slabosz A; Robbins TW; Barker RA; Owen AM
Neuropsychologia; 2005; 43(6):823-32. PubMed ID: 15716155
[TBL] [Abstract][Full Text] [Related]
20. Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain.
Park HS; Kim CJ; Kwak HB; No MH; Heo JW; Kim TW
Neuropharmacology; 2018 May; 133():451-461. PubMed ID: 29477301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
